Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony F Yu

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Heart (British Cardiac Society)|December 18, 2015
Roadmap for biomarkers of cancer therapy cardiotoxicityAnthony F Yu, Bonnie Ky
Journal of the American College of Cardiology|June 30, 2022
ARIC Welcomes Cancer Survivors Into Their Communities: Unraveling the Link Between Cancer and Cardiovascular DiseaseAnthony F Yu, Richard M Steingart
Current Treatment Options in Oncology|May 11, 2019
Cardiotoxicity of Contemporary Breast Cancer TreatmentsKatherine Lee Chuy, Anthony F Yu
Future Cardiology|August 4, 2015
Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic trainingAnthony F Yu, Lee W Jones
JACC. Asia|December 20, 2025
Toward Personalized CTRCD Risk Prediction: CHECK HEART Offers a Preliminary FrameworkJoseph S Wallins, Anthony F Yu
Cardio-Oncology (London, England)|January 31, 2017
Breast cancer treatment-associated cardiovascular toxicity and effects of exercise countermeasuresAnthony F Yu, Lee W Jones
Journal of Cardiac Failure|August 25, 2014
Cardiomyopathy associated with cancer therapyAnthony F Yu, Richard M Steingart, Valentin Fuster
JACC. Cardiooncology|August 16, 2021
Trastuzumab Cures Cancer and Disrupts the Practice of CardiologyRichard M Steingart, Anthony F Yu, Chau T Dang
Heart Asia|June 22, 2016
Apical ballooning syndrome precipitated by dobutamine stress testingAnthony F Yu, Sumeet S Mitter, Hina W Chaudhry
Journal of the American College of Cardiology|February 21, 2019
Cardiac Magnetic Resonance and Cardio-Oncology: Does T<sub>2</sub> Signal the End of Anthracycline Cardiotoxicity?Anthony F Yu, Angel T Chan, Richard M Steingart
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Heart (British Cardiac Society)|December 18, 2015
Roadmap for biomarkers of cancer therapy cardiotoxicityAnthony F Yu, Bonnie Ky
Journal of the American College of Cardiology|June 30, 2022
ARIC Welcomes Cancer Survivors Into Their Communities: Unraveling the Link Between Cancer and Cardiovascular DiseaseAnthony F Yu, Richard M Steingart
Current Treatment Options in Oncology|May 11, 2019
Cardiotoxicity of Contemporary Breast Cancer TreatmentsKatherine Lee Chuy, Anthony F Yu
Future Cardiology|August 4, 2015
Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic trainingAnthony F Yu, Lee W Jones
JACC. Asia|December 20, 2025
Toward Personalized CTRCD Risk Prediction: CHECK HEART Offers a Preliminary FrameworkJoseph S Wallins, Anthony F Yu
Cardio-Oncology (London, England)|January 31, 2017
Breast cancer treatment-associated cardiovascular toxicity and effects of exercise countermeasuresAnthony F Yu, Lee W Jones
Journal of Cardiac Failure|August 25, 2014
Cardiomyopathy associated with cancer therapyAnthony F Yu, Richard M Steingart, Valentin Fuster
JACC. Cardiooncology|August 16, 2021
Trastuzumab Cures Cancer and Disrupts the Practice of CardiologyRichard M Steingart, Anthony F Yu, Chau T Dang
Heart Asia|June 22, 2016
Apical ballooning syndrome precipitated by dobutamine stress testingAnthony F Yu, Sumeet S Mitter, Hina W Chaudhry
Journal of the American College of Cardiology|February 21, 2019
Cardiac Magnetic Resonance and Cardio-Oncology: Does T<sub>2</sub> Signal the End of Anthracycline Cardiotoxicity?Anthony F Yu, Angel T Chan, Richard M Steingart
Pageof 7